홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Dimethylamine → 10-(((4-Acetyl-1-piperazinyl)(oxo)acetyl)amino)-N-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide

HRID 1093133
인쇄

반응식

HRID 1093133 반응식
[F:1][C:2]1[CH:37]=[CH:36][C:5]([CH2:6][NH:7][C:8]([C:10]2[N:11]=[C:12]3[C:18]4([NH:21][C:22](=[O:31])[C:23](=[O:30])[N:24]5[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]5)[CH2:19][CH2:20][CH:15]([CH2:16][CH2:17]4)[CH2:14][N:13]3[C:32](=[O:35])[C:33]=2[OH:34])=[O:9])=[CH:4][CH:3]=1.C(N(CC)CC)C.[C:45](Cl)(=[O:47])[CH3:46].CNC>C(Cl)Cl.CO>[C:45]([N:27]1[CH2:26][CH2:25][N:24]([C:23](=[O:30])[C:22]([NH:21][C:18]23[CH2:19][CH2:20][CH:15]([CH2:16][CH2:17]2)[CH2:14][N:13]2[C:32](=[O:35])[C:33]([OH:34])=[C:10]([C:8]([NH:7][CH2:6][C:5]4[CH:4]=[CH:3][C:2]([F:1])=[CH:37][CH:36]=4)=[O:9])[N:11]=[C:12]32)=[O:31])[CH2:29][CH2:28]1)(=[O:47])[CH3:46]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 674DimethylamineHCID 6367Acetyl chlorideHCID 8471TriethylamineHCID 57904939N-(4-Fluorobenzyl)-3-hydroxy-4-oxo-10-((oxo(1-piperazinyl)acetyl)amino)-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide

생성물 1

HCID 5790502810-(((4-Acetyl-1-piperazinyl)(oxo)acetyl)amino)-N-(4-fluorobenzyl)-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide
수율 47.8%

시약·촉매·용매 2

HCID 887Methanol용매2회HCID 6344Dichloromethane용매

실험 절차

To a solution of N-(4-fluorobenzyl)-3-hydroxy-4-oxo-10-((oxo(1-piperazinyl)acetyl)amino)-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide (25 mg, 0.049 mmol) in CH2Cl2 (2 mL) was added triethylamine (0.034 mL, 0.244 mmol), followed by acetyl chloride (0.017 mL, 0.244 mmol) and the resulting mixture stirred at room temperature. After 16 h, the reaction mixture was concentrated to give crude product which was dissolved in methanol (2 mL) and treated with 2M dimethylamine in methanol (0.5 mL). The resulting reaction mixture was stirred at 60° C. for 2 h then cooled and purified by preparative HPLC to afford the title compound as a brown solid (13 mg, 46% yield). 1H NMR (500 MHz, CDCl3) δ: 12.05 (1 H, brs), 8.53 (1 H, brs), 8.48 (1 78, 5.65 Hz), 7.07 (2H, t, J=8.24 Hz), 4.66 (2 H, d, J=5.80 Hz), 4.24 (2 H, d, J=3.05 Hz), 4.18 (1 H, brs), 3.95-4.03 (1 H, m), 3.75 (2 H, brs), 3.46-3.63 (4 H, m), 2.64-2.73 (2 H, m), 2.51-2.58 (1 H, m), 2.11 (3 H, d, J=9.46 Hz), 1.95-2.14 (4 H, m), 1.76-1.82 (2 H, m). LCMS (M+H)=555.56. HPLC purity: >95%.

후처리

  1. concentrationthe reaction mixture was concentrated
  2. customto give crude product which
  3. customThe resulting reaction mixture
  4. stirringwas stirred at 60° C. for 2 h
  5. temperaturethen cooled
  6. custompurified by preparative HPLC

출처 및 근거

ORD 기록
ord-caf578c26d93440ca729c0c020f6f979
출처 데이터셋
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08129398B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트